Michael Running Sells 510 Shares of Plexus (NASDAQ:PLXS) Stock

Plexus Corp. (NASDAQ:PLXSGet Free Report) insider Michael Running sold 510 shares of Plexus stock in a transaction on Friday, June 5th. The stock was sold at an average price of $272.17, for a total value of $138,806.70. Following the completion of the sale, the insider directly owned 665 shares of the company’s stock, valued at $180,993.05. The trade was a 43.40% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Plexus Stock Performance

Shares of PLXS traded up $9.28 during trading hours on Monday, hitting $282.29. The stock had a trading volume of 416,459 shares, compared to its average volume of 338,922. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.54 and a quick ratio of 0.74. Plexus Corp. has a 12 month low of $115.35 and a 12 month high of $292.33. The firm has a market capitalization of $7.55 billion, a PE ratio of 41.27 and a beta of 0.89. The stock has a fifty day moving average price of $245.12 and a 200 day moving average price of $199.73.

Plexus (NASDAQ:PLXSGet Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The technology company reported $2.05 EPS for the quarter, topping the consensus estimate of $1.87 by $0.18. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The company had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.13 billion. During the same quarter in the previous year, the company posted $1.66 earnings per share. Plexus’s revenue was up 18.7% compared to the same quarter last year. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Analysts anticipate that Plexus Corp. will post 5.98 EPS for the current year.

Analysts Set New Price Targets

PLXS has been the subject of several research analyst reports. Stifel Nicolaus set a $280.00 price objective on Plexus in a report on Tuesday, May 26th. Raymond James Financial reiterated an “outperform” rating and set a $275.00 target price on shares of Plexus in a research report on Thursday, April 30th. Benchmark reiterated a “buy” rating and set a $220.00 target price on shares of Plexus in a research report on Monday, March 16th. Weiss Ratings raised Plexus from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, May 11th. Finally, Zacks Research lowered Plexus from a “hold” rating to a “strong sell” rating in a report on Wednesday, May 20th. Five analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $238.33.

View Our Latest Report on Plexus

Institutional Investors Weigh In On Plexus

A number of institutional investors and hedge funds have recently bought and sold shares of the business. American Century Companies Inc. raised its position in Plexus by 44.2% in the 3rd quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock worth $159,722,000 after purchasing an additional 338,119 shares during the period. Victory Capital Management Inc. raised its stake in shares of Plexus by 130.0% during the 4th quarter. Victory Capital Management Inc. now owns 349,057 shares of the technology company’s stock worth $51,311,000 after acquiring an additional 197,283 shares in the last quarter. Emerald Advisers LLC bought a new position in shares of Plexus during the 1st quarter worth approximately $33,729,000. MetLife Investment Management LLC raised its stake in shares of Plexus by 713.3% during the 4th quarter. MetLife Investment Management LLC now owns 126,971 shares of the technology company’s stock worth $18,665,000 after acquiring an additional 111,360 shares in the last quarter. Finally, Emerald Mutual Fund Advisers Trust bought a new position in shares of Plexus during the 1st quarter worth approximately $20,715,000. 94.45% of the stock is owned by institutional investors.

Plexus Company Profile

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Featured Stories

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.